CinCor Pharma Accounts Payable

CinCor Pharma (CINC) currently reports a accounts payable of $2.6M as of September 2022. That compares with $4M in the prior-year period — down 35.4% year over year. Use the charts on this page to explore CinCor Pharma's accounts payable history and peer comparisons.

CinCor Pharma's accounts payable decreased from $4M to $2.6M — a 35.4% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CinCor Pharma reported $2.6M in accounts payable as of September 2022. That compares with $4M in the prior-year period — down 35.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $2.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CinCor Pharma, and consider following CINC for alerts when major investors trade the stock.